Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 12Breast 6Genitourinary 4Other 3Lymphoid 2Thoracic 1Other hematologic neoplasm 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Psychotic Disorders 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuralgia 1Lymphoma, Follicular 1Bipolar Disorder 1

Interventions

Rituximab 1371Cyclophosphamide 1297Vincristine 662Doxorubicin 583Etoposide 525Prednisone 505Cytarabine 481fludarabine 462Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 255ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 228Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Gabapentin × Lymphoid × Clear all
NCT05064319 2025-07-08

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

Medical University of South Carolina

Phase 2 Recruiting
68 enrolled
Lymphoid

Bipolar Disorder, Lymphoma, Follicular, Psychotic Disorders

NCT01506453 2019-06-19

TINALL

St. Jude Children's Research Hospital

Phase 2 Completed
51 enrolled 7 charts
LymphoidOther hematologic neoplasm

Neuralgia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡